Literature DB >> 12831851

Effects of adenosine on gabaergic synaptic inputs to identified ventrolateral preoptic neurons.

N L Chamberlin1, E Arrigoni, T C Chou, T E Scammell, R W Greene, C B Saper.   

Abstract

The ventrolateral preoptic nucleus (VLPO) is a key regulator of behavioral state that promotes sleep by directly inhibiting brain regions that maintain wakefulness. Subarachnoid administration of adenosine (AD) or AD agonists promotes sleep and induces expression of Fos protein in VLPO neurons. Therefore, activation of VLPO neurons may contribute to the somnogenic actions of AD. To define the mechanism through which AD activates VLPO neurons, we prepared hypothalamic slices from 9 to 12-day-old rat pups and recorded from 43 neurons in the galaninergic VLPO cluster; nine neurons contained galanin mRNA by post hoc in situ hybridization. Bath application of AD (20 microM) to seven of these neurons had no direct effect but caused a significant decrease in the frequency of spontaneous miniature inhibitory postsynaptic currents in the presence of tetrodotoxin, indicating a presynaptic site of action. We conclude that AD-mediated disinhibition increases the excitability of VLPO neurons thus contributing to the somnogenic properties of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831851     DOI: 10.1016/s0306-4522(03)00246-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  37 in total

1.  Mathematical model of network dynamics governing mouse sleep-wake behavior.

Authors:  Cecilia G Diniz Behn; Emery N Brown; Thomas E Scammell; Nancy J Kopell
Journal:  J Neurophysiol       Date:  2007-04-04       Impact factor: 2.714

2.  The preoptic hypothalamus and basal forebrain play opposing roles in the descending modulation of sleep and wakefulness in infant rats.

Authors:  Ethan J Mohns; Karl A E Karlsson; Mark S Blumberg
Journal:  Eur J Neurosci       Date:  2006-03       Impact factor: 3.386

Review 3.  The energy hypothesis of sleep revisited.

Authors:  Matthew T Scharf; Nirinjini Naidoo; John E Zimmerman; Allan I Pack
Journal:  Prog Neurobiol       Date:  2008-09-03       Impact factor: 11.685

4.  Efferent projections from the median preoptic nucleus to sleep- and arousal-regulatory nuclei in the rat brain.

Authors:  A Uschakov; H Gong; D McGinty; R Szymusiak
Journal:  Neuroscience       Date:  2007-09-12       Impact factor: 3.590

5.  Microinjection of adenosine into the hypothalamic ventrolateral preoptic area enhances wakefulness via the A1 receptor in rats.

Authors:  Jin Zhang; Dou Yin; Fang Wu; Gongliang Zhang; Chuanwei Jiang; Zhen Li; Liecheng Wang; Kai Wang
Journal:  Neurochem Res       Date:  2013-05-09       Impact factor: 3.996

6.  Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal.

Authors:  Rhannan H Williams; Melissa J S Chee; Daniel Kroeger; Loris L Ferrari; Eleftheria Maratos-Flier; Thomas E Scammell; Elda Arrigoni
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 7.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

8.  The role of PHOX2B-derived astrocytes in chemosensory control of breathing and sleep homeostasis.

Authors:  Catherine M Czeisler; Talita M Silva; Summer R Fair; Jillian Liu; Srinivasan Tupal; Behiye Kaya; Aaron Cowgill; Salil Mahajan; Phelipe E Silva; Yangyang Wang; Angela R Blissett; Mustafa Göksel; Jeremy C Borniger; Ning Zhang; Silvio A Fernandes-Junior; Fay Catacutan; Michele J Alves; Randy J Nelson; Vishnu Sundaresean; Jens Rekling; Ana C Takakura; Thiago S Moreira; José J Otero
Journal:  J Physiol       Date:  2019-03-19       Impact factor: 5.182

9.  Adenosine and sleep.

Authors:  Theresa E Bjorness; Robert W Greene
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  New approaches for the study of orexin function.

Authors:  A Yamanaka; T Tsunematsu
Journal:  J Neuroendocrinol       Date:  2010-05-04       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.